Naldemedine clinical trials
Also written Symproic® and S-297995.
How each study uses naldemedine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the naldemedine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 23 Mar 2017 · SYMPROIC · NDA 208854 (FDA, Drugs@FDA)
- European Union
- 18 Feb 2019 · Rizmoic · EMEA/H/C/004256 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2013 (3)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 3 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 3
Shionogi (7) · Asbjørn Mohr Drewes (2) · International University of Health and Welfare (1)
Studies
Open first, then newest update. How each study uses naldemedine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 10
- Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving OpioidsRecruitingPhase 1/2ShionogiNCT05588323Written as NaldemedineHow we know
- The Effect of Naldemedine on Opioid-induced Bowel DysfunctionRecruitingPhase 2Asbjørn Mohr DrewesNCT06334198Written as NaldemedineHow we know
- Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON StudyCompletedPhase 4International University of Health and WelfareNCT07038551Written as NaldemedineHow we know
- Effects of a Peripherally Acting µ-opioid Receptor Antagonist on Recurrent Acute PancreatitisActive, not recruitingPhase 2/3Asbjørn Mohr DrewesNCT04966559Written as Naldemedine 0.2 MG Oral TabletHow we know
- A Study of Naldemedine in Participants Undergoing Surgeries That Include a Bowel Resection or Bowel TransectionTerminatedPhase 2ShionogiNCT04355169Written as NaldemedineHow we know
- Long Term Safety of NaldemedineCompletedPhase 3ShionogiNCT01965652Written as NaldemedineHow we know
- A Study of Naldemedine (S-297995) for the Treatment of Opioid-Induced Constipation in Adults With Non-Malignant Chronic Pain Receiving Opioid TherapyCompletedPhase 2ShionogiNCT01443403Written as NaldemedineHow we know
- Study to Evaluate the Safety and Efficacy of Naldemedine (S-297995) for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic PainCompletedPhase 2ShionogiNCT01122030Written as NaldemedineHow we know
- Efficacy and Safety of Naldemedine in Treating Opioid-induced ConstipationCompletedPhase 3ShionogiNCT01993940Written as NaldemedineHow we know
- Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced ConstipationCompletedPhase 3ShionogiNCT01965158Written as NaldemedineHow we know
Codes
What other systems call naldemedine · ClinicalTrials.gg INT000715
- MeSH (NLM) C000620491naldemedineConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 03KSI6WLXHNALDEMEDINEConfirmed FDA, NLM, Wikidata
- RxNorm 1876597Confirmed FDA, Wikidata
- Wikidata Q6960846naldemedineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C175156NaldemedineOne source FDA
- DrugBank DB11691One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000620491 | naldemedine | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 03KSI6WLXH | NALDEMEDINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1876597 | — | Confirmed FDA, Wikidata |
| Wikidata | Q6960846 | naldemedine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C175156 | Naldemedine | One source FDA |
| DrugBank | DB11691 | — | One source Wikidata |
Also registered as naldemedine tosylate (UNII V1N8F1RVVO · RxNorm 1876598).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.